Clinical Trials Browser

Phase 1 × Advanced Malignancies × Capecitabine × Clear all

NCT00083525 2008-01-24

Urokinase-Plasminogen Activator (uPA) Inhibitor WX-UK1 in Combination With Capecitabine in Advanced Malignancies

Phase 1 Completed

Advanced Malignancies